Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore — See source for full details.
$KLRA
Price history, market instrument context, member research, and related headlines in one place.
KLRA key statistics
NasdaqGSUSD
52-week range
$9.765%$28.23
Latest session $10.44–$10.99Kailera Therapeutics, Inc. (KLRA) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $10.74, down $0.03 (0.28%) from the previous close of $10.77. It has traded between $10.44 and $10.99 in the latest session. Over the past year it has ranged from $9.76 to $28.23, leaving it in the lower quarter of its 52-week range (5%). Reported volume for the session was 1.3M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Kailera Therapeutics, Inc. reports Q2 results — See source for full details.
Loading $KLRA research…